Results 321 to 330 of about 361,202 (360)

Heterologicality

Analysis, 1951
openaire   +1 more source

Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study

Lancet Respiratory Medicine,the, 2021
David Hillus, Tatjana Schwarz, Pinkus Tober-Lau   +2 more
exaly  

heterologal, adj.

2023
openaire   +1 more source

SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition

Nature Immunology, 2020
Annika Nelde, Tatjana Bilich, Jonas S Heitmann   +2 more
exaly  

Immunogenicity and safety of NVSI-06-07 as a heterologous booster after priming with BBIBP-CorV: a phase 2 trial

Signal Transduction and Targeted Therapy, 2022
Nawal Al Kaabi, Sally A Mahmoud, Xiao-Ming Yang   +2 more
exaly  

Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants

Science, 2022
Catherine J Reynolds, Joseph M Gibbons, Corinna Pade   +2 more
exaly  

Primeness and Heterologicality

Analysis, 1953
openaire   +1 more source

Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant

Nature Communications, 2022
Fanglei Zuo, Hassan Abolhassani, Antonio Piralla   +2 more
exaly  

Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia

Lancet, The, 2020
Denis Y Logunov, Inna V Dolzhikova, Amir I Tukhvatulin   +2 more
exaly  

Heterology

2017
openaire   +1 more source